Browse by Title

Type here to filter the list

S
SAFETY AND EFFICACY UPDATES FROM A PHASE 1 STUDY OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (Paper 27)
Favorite

Hans Gelderblom, MD, PhD (he/him/his) – Leiden University Medical Center ### 2101884###Author###Medical Oncologist###Leiden University Medical Center###
Author: Hans Gelderblom, MD, PhD (he/him/his) – Leiden University Medical Center
### he/him/his @@@ Albiruni Ryan Abdul Razak, MB BCh, BM BCh – Princess Margaret Cancer Center ### 2101867###Co-Author######Princess Margaret Cancer Center###
Co-Author: Albiruni Ryan Abdul Razak, MB BCh, BM BCh – Princess Margaret Cancer Center
### @@@ Javier Martin-Broto, MD, PhD (he/him/his) – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology ### 2101868###Co-Author###Medical oncology###Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology###
Co-Author: Javier Martin-Broto, MD, PhD (he/him/his) – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology
### he/him/his @@@ Breelyn A. Wilky, MD – University of Colorado Cancer Center ### 2101885###Co-Author######University of Colorado Cancer Center###
Co-Author: Breelyn A. Wilky, MD – University of Colorado Cancer Center
### @@@ Piotr Rutkowski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma ### 2101886###Co-Author###Head of Department of Soft Tissue/Bone Sarcoma and Melanoma###Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma###
Co-Author: Piotr Rutkowski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma
### @@@ Nicholas Bernthal, MD – University of California Los Angeles ### 2101887###Co-Author######University of California Los Angeles###
Co-Author: Nicholas Bernthal, MD – University of California Los Angeles
### @@@ Supraja Narasimhan, MS, PhD – Deciphera Pharmaceuticals, LLC ### 2101888###Co-Author###Associate Director, Clinical Scientist###Deciphera Pharmaceuticals, LLC###
Co-Author: Supraja Narasimhan, MS, PhD – Deciphera Pharmaceuticals, LLC
### @@@ Maitreyi G. Sharma, MD (she/her/hers) – Deciphera Pharmaceuticals, LLC ### 2101889###Co-Author###VP, Late Clinical Development###Deciphera Pharmaceuticals, LLC###
Co-Author: Maitreyi G. Sharma, MD (she/her/hers) – Deciphera Pharmaceuticals, LLC
### she/her/hers @@@ Rodrigo Ruiz-Soto, MD/MSc (he/him/his) – Deciphera Pharmaceuticals, LLC ### 2101890###Co-Author###Sr. Vice President Clinical Development###Deciphera Pharmaceuticals, LLC###
Co-Author: Rodrigo Ruiz-Soto, MD/MSc (he/him/his) – Deciphera Pharmaceuticals, LLC
### he/him/his @@@ Matthew L. Sherman, MD – Deciphera Pharmaceuticals, LLC ### 2101891###Co-Author######Deciphera Pharmaceuticals, LLC###
Co-Author: Matthew L. Sherman, MD – Deciphera Pharmaceuticals, LLC
### @@@ William D. Tap, MD – Memorial Sloan Kettering Cancer Center ### 2101892###Co-Author###Chief, Sarcoma Medical Oncology###Memorial Sloan Kettering Cancer Center###
Co-Author: William D. Tap, MD – Memorial Sloan Kettering Cancer Center
### Paper 27
Sarcoma Survivor and Patient Advocate
Favorite

Carol Haslem ### 2170524###Presenter#########
Presenter: Carol Haslem
###
Sarcoma Survivor: Patient Experience
Favorite
SELECTIVE TRANS-ARTERIAL EMBOLOTHERAPY FOR PRIMARY AND METASTATIC SOFT TISSUE TUMORS (Video 07)
Favorite

Eldad Elnekave, MD (he/him/his) – SZMC ### 1794267###Video Presenter###Interventional Oncology Unit###SZMC###
Video Presenter: Eldad Elnekave, MD (he/him/his) – SZMC
### he/him/his @@@ Sivan Shamai, MD – Sourasky Medical Center ### 1803344###Co-Author######Sourasky Medical Center###
Co-Author: Sivan Shamai, MD – Sourasky Medical Center
### @@@ Alona Zer, MD – Rambam Medical Center ### 1803357###Co-Author###Director of Oncology###Rambam Medical Center###
Co-Author: Alona Zer, MD – Rambam Medical Center
### @@@ Eytan Ben Ami, MD – Sheba Medical Center ### 1803343###Co-Author######Sheba Medical Center###
Co-Author: Eytan Ben Ami, MD – Sheba Medical Center
### @@@ Daniela Katz, MD, MHA – Helmsley Cancer Center, Shaare Zedek Medical Center, Jerusalem Israel ### 2104546###Co-Author###Medical Oncologist, Helmsley Cancer Center, Shaare Zedek ###Helmsley Cancer Center, Shaare Zedek Medical Center, Jerusalem Israel###
Co-Author: Daniela Katz, MD, MHA – Helmsley Cancer Center, Shaare Zedek Medical Center, Jerusalem Israel
### Video 07
Session 1: Improving Sarcoma Care Globally: Access, Equity, Advocacy, and Policy
Favorite

B Ashleigh Guadagnolo, MD,MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2102052###Chair###Professor###The University of Texas MD Anderson Cancer Center###
Chair: B Ashleigh Guadagnolo, MD,MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Bernd Kasper, MD, PhD (he/him/his) – University of Heidelberg, Mannheim University Medical Center ### 2102343###Moderator###Professor###University of Heidelberg, Mannheim University Medical Center###
Moderator: Bernd Kasper, MD, PhD (he/him/his) – University of Heidelberg, Mannheim University Medical Center
### he/him/his @@@ Nadia Hindi, MD, MSc – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology ### 2102400###Moderator###Medical Oncologist###Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology###
Moderator: Nadia Hindi, MD, MSc – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology
### @@@ Angela M. Hong, MBBS, MMed, PhD, FRANZCR – Sydney Medical School, The University of Sydney and Department of Radiation Oncology, Chris O’Brien Lifehouse, Sydney Australia. ### 1429837###Moderator###Prof###Sydney Medical School, The University of Sydney and Department of Radiation Oncology, Chris O’Brien Lifehouse, Sydney Australia.###
Moderator: Angela M. Hong, MBBS, MMed, PhD, FRANZCR – Sydney Medical School, The University of Sydney and Department of Radiation Oncology, Chris O’Brien Lifehouse, Sydney Australia.
###
Session 10: Trials in Progress
Favorite

Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong ### 2101862###Chair###Clinical Associate Professor###The Chinese University of Hong Kong###
Chair: Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong
### he/him/his @@@ Liz Connolly, FRACP MRCPUK MBCHB – Chris O Brien Lifehouse ### 1094367###Moderator###Sarcoma Fellow (medical oncology)###Chris O Brien Lifehouse###
Moderator: Liz Connolly, FRACP MRCPUK MBCHB – Chris O Brien Lifehouse
### @@@ Thierry Alcindor, MD – Harvard University,, Dana-Farber Cancer Center ### 2102523###Moderator######Harvard University,, Dana-Farber Cancer Center###
Moderator: Thierry Alcindor, MD – Harvard University,, Dana-Farber Cancer Center
### @@@ Mark Doherty, MB BCh BAO MSc MRCPI (he/him/his) – St Vincents University Hospital ### 2104450###Moderator###Consultant Medical Oncologist###St Vincents University Hospital###
Moderator: Mark Doherty, MB BCh BAO MSc MRCPI (he/him/his) – St Vincents University Hospital
### he/him/his
Session 11: Bone Sarcomas
Favorite

Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong ### 2101862###Chair###Clinical Associate Professor###The Chinese University of Hong Kong###
Chair: Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong
### he/him/his @@@ alan Molloy, n/a – St Vincents University Hospital ### 2105294###Moderator###Consultant Orthopaedic Surgeon###St Vincents University Hospital###
Moderator: alan Molloy, n/a – St Vincents University Hospital
### @@@ Sandra J. Strauss, MD, FRCP, PhD (he/him/his) – University College, London ### 1136431###Moderator###Professor of Medical and TYA Oncology###University College, London###
Moderator: Sandra J. Strauss, MD, FRCP, PhD (he/him/his) – University College, London
### he/him/his @@@ Shintaro Iwata, MD (he/him/his) – National Cancer Center Hospital ### 2102737###Moderator###Assistant chief###National Cancer Center Hospital###
Moderator: Shintaro Iwata, MD (he/him/his) – National Cancer Center Hospital
### he/him/his
Session 12: Preclinical Models and Translational Research
Favorite

Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON ### 2101973###Chair###Surgical Oncologist Clinician-Scientist Associate Professor of Surgery###Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON###
Chair: Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
### she/her/hers @@@ Sandro Pasquali, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2102575###Moderator######Fondazione IRCCS Istituto Nazionale dei Tumori###
Moderator: Sandro Pasquali, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Ana Banito, PhD – Hopp Children's Cancer Center, German Cancer Research Center ### 1431056###Moderator###Assistant Professor###Hopp Children's Cancer Center, German Cancer Research Center###
Moderator: Ana Banito, PhD – Hopp Children's Cancer Center, German Cancer Research Center
### @@@ Brian Andrew Van Tine, MD, PhD (he/him/his) – Washington University School of Medicine ### 2102118###Moderator###Professor of Medicine###Washington University School of Medicine###
Moderator: Brian Andrew Van Tine, MD, PhD (he/him/his) – Washington University School of Medicine
### he/him/his
Session 13: Retroperitoneal and Abdominal Sarcomas
Favorite

Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON ### 2101973###Chair###Surgical Oncologist Clinician-Scientist Associate Professor of Surgery###Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON###
Chair: Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
### she/her/hers @@@ Aimee M. Crago, MD, PhD, FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2102032###Moderator###Associate Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Moderator: Aimee M. Crago, MD, PhD, FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Paul Ridgway, n/a – Tallaght University Hospital ### 2105292###Moderator###Consultant Surgeon###Tallaght University Hospital###
Moderator: Paul Ridgway, n/a – Tallaght University Hospital
###
Session 14: GIST
Favorite

Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong ### 2101862###Chair###Clinical Associate Professor###The Chinese University of Hong Kong###
Chair: Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong
### he/him/his @@@ Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School ### 1137185###Moderator###Surgical Oncologist###Brigham and Women’s Hospital/Harvard Medical School###
Moderator: Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School
### he/him/his @@@ Anette Duensing, MD – University of Pittsburgh School of Medicine ### 1805765###Moderator###Associate Professor###University of Pittsburgh School of Medicine###
Moderator: Anette Duensing, MD – University of Pittsburgh School of Medicine
### @@@ Toto Hølmebakk, MD, PhD (he/him/his) – Oslo University Hospital, The Norwegian Radium Hospital ### 2103615###Moderator###Consultant Surgeon###Oslo University Hospital, The Norwegian Radium Hospital###
Moderator: Toto Hølmebakk, MD, PhD (he/him/his) – Oslo University Hospital, The Norwegian Radium Hospital
### he/him/his
Session 15: Awards Session
Favorite

Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada ### 2101979###Chair######Mount Sinai Hospital, Toronto, ON, Canada###
Chair: Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada
### @@@ Jakob Hofvander, PhD (he/him/his) – Lund University ### 2120666###Young Investigator Award Winner###Postdoc###Lund University###
Young Investigator Award Winner: Jakob Hofvander, PhD (he/him/his) – Lund University
### he/him/his @@@ Josephine K. Dermawan, MD, PhD – Cleveland Clinic ### 2120660###Young Investigator Award Winner###Associate Staff###Cleveland Clinic###
Young Investigator Award Winner: Josephine K. Dermawan, MD, PhD – Cleveland Clinic
### @@@ Alison Yoder, MD MPH – MDACC ### 2102053###Young Investigator Award Winner###Resident Physician###MDACC###
Young Investigator Award Winner: Alison Yoder, MD MPH – MDACC
### @@@ Mandy L. Ballinger, BAppSc BSc MSc PhD (she/her/hers) – Garvan Institute of Medical Research ### 1431231###Liddy Shriver Early Research Award Winner###Group Leader###Garvan Institute of Medical Research###
Liddy Shriver Early Research Award Winner: Mandy L. Ballinger, BAppSc BSc MSc PhD (she/her/hers) – Garvan Institute of Medical Research
### she/her/hers @@@ David Kirsch, MD, PhD – Princess Margaret Cancer Centre/University Health Network ### 2103188###Basic Science Sarcoma Research Award Winner###Head, Radiation Medicine Program###Princess Margaret Cancer Centre/University Health Network###
Basic Science Sarcoma Research Award Winner: David Kirsch, MD, PhD – Princess Margaret Cancer Centre/University Health Network
### @@@ Benjamin Nacev, MD, PhD – University of Pittsburgh Hillman Cancer Center ### 2103357###Basic Science Sarcoma Research Award Winner###Assistant Professor###University of Pittsburgh Hillman Cancer Center###
Basic Science Sarcoma Research Award Winner: Benjamin Nacev, MD, PhD – University of Pittsburgh Hillman Cancer Center
### @@@ Isidro Cortes-Ciriano, PhD – EMBL-EBI ### 2102521###Basic Science Sarcoma Research Award Winner###Research Group Leader###EMBL-EBI###
Basic Science Sarcoma Research Award Winner: Isidro Cortes-Ciriano, PhD – EMBL-EBI
###
Session 2: Sarcoma Biology and 'Omics
Favorite

Maureen J. O'Sullivan, MBBCh, MD, FRCPath – Children's Health Ireland & Trinity College, Dublin, IRELAND ### 1136423###Chair###Consultant/Professor###Children's Health Ireland & Trinity College, Dublin, IRELAND###
Chair: Maureen J. O'Sullivan, MBBCh, MD, FRCPath – Children's Health Ireland & Trinity College, Dublin, IRELAND
### @@@ Alejandro Sweet-Cordero, MD – UCSF ### 2102600###Moderator###Chief of Pediatric Oncology, Department of Pediatrics, UCSF; Professor of Pediatrics;###UCSF###
Moderator: Alejandro Sweet-Cordero, MD – UCSF
### @@@ Brian D. Crompton, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center ### 2102350###Moderator###Co-Director for Research, Pediatric Solid Tumor Program Assistant Professor of Pediatrics, Harvard Medical School Associate Member, Broad Institute of Harvard and MIT Dana-Farber/Boston Children’s Cancer and Blood Disorders Center###Dana-Farber/Boston Children's Cancer and Blood Disorders Center###
Moderator: Brian D. Crompton, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center
### @@@ Sarah Watson, MD, PhD – Institut Curie ### 2102690###Moderator###Clinician Scientist###Institut Curie###
Moderator: Sarah Watson, MD, PhD – Institut Curie
###
Session 3: Radiation Oncology: Updates, Innovations, & Controversies
Favorite

B Ashleigh Guadagnolo, MD,MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2102052###Chair###Professor###The University of Texas MD Anderson Cancer Center###
Chair: B Ashleigh Guadagnolo, MD,MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Kilian E. Salerno, MD (she/her/hers) – Radiation Oncology Branch | National Cancer Institute | National Institutes of Health ### 2128327###Moderator###Associate Research Physician###Radiation Oncology Branch | National Cancer Institute | National Institutes of Health###
Moderator: Kilian E. Salerno, MD (she/her/hers) – Radiation Oncology Branch | National Cancer Institute | National Institutes of Health
### she/her/hers @@@ Peter Chung, MBChB MRCP FRCR FRCPC – Princess Margaret Cancer Centre ### 2101949###Moderator###Radiation Oncologist###Princess Margaret Cancer Centre###
Moderator: Peter Chung, MBChB MRCP FRCR FRCPC – Princess Margaret Cancer Centre
### @@@ Charles Gillham, MRCP FRCR MD (he/him/his) – St Luke's Radiation Oncology Network ### 2102216###Moderator###Network Director###St Luke's Radiation Oncology Network###
Moderator: Charles Gillham, MRCP FRCR MD (he/him/his) – St Luke's Radiation Oncology Network
### he/him/his
Session 4: Medical and Pediatric Oncology Trials
Favorite

Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong ### 2101862###Chair###Clinical Associate Professor###The Chinese University of Hong Kong###
Chair: Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong
### he/him/his @@@ Sebastian Bauer, MD (he/him/his) – Department of Medical Oncology, West German Cancer Center, University Hospital Essen ### 2101909###Moderator###Attending, Director Sarcoma Center###Department of Medical Oncology, West German Cancer Center, University Hospital Essen###
Moderator: Sebastian Bauer, MD (he/him/his) – Department of Medical Oncology, West German Cancer Center, University Hospital Essen
### he/him/his @@@ Valerie S. Yang, MB BChir (Cantab), PhD (Cantab), MRCP (UK), FAMS (Medical Oncology) (Clinician Scientists) (she/her/hers) – Division of Medical Oncology, National Cancer Centre Singapore ### 1771539###Moderator###Assistant Professor###Division of Medical Oncology, National Cancer Centre Singapore###
Moderator: Valerie S. Yang, MB BChir (Cantab), PhD (Cantab), MRCP (UK), FAMS (Medical Oncology) (Clinician Scientists) (she/her/hers) – Division of Medical Oncology, National Cancer Centre Singapore
### she/her/hers @@@ Lara Davis, MD (she/her/hers) – OHSU Knight Cancer Institute ### 2102059###Moderator###Associate Professor###OHSU Knight Cancer Institute###
Moderator: Lara Davis, MD (she/her/hers) – OHSU Knight Cancer Institute
### she/her/hers @@@ Lu Xie, MD (she/her/hers) – Peking University People's Hospital ### 1094290###Moderator###consultant and vice director of Musculoskeletal Tumor Center###Peking University People's Hospital###
Moderator: Lu Xie, MD (she/her/hers) – Peking University People's Hospital
### she/her/hers
Session 5: Immunology and Immunotherapy
Favorite

Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong ### 2101862###Chair###Clinical Associate Professor###The Chinese University of Hong Kong###
Chair: Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong
### he/him/his @@@ Neeta Somaiah, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2101912###Moderator###Associate Professor and Deputy Chair###The University of Texas MD Anderson Cancer Center###
Moderator: Neeta Somaiah, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Everett J. Moding, MD, PhD (he/him/his) – Stanford University ### 2102687###Moderator###Assistant Professor###Stanford University###
Moderator: Everett J. Moding, MD, PhD (he/him/his) – Stanford University
### he/him/his @@@ Javier Martin-Broto, MD, PhD (he/him/his) – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology ### 2101868###Moderator###Medical oncology###Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology###
Moderator: Javier Martin-Broto, MD, PhD (he/him/his) – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology
### he/him/his
Session 6: Sarcoma of the Year: Small Round Blue Cell Tumor
Favorite

Maureen J. O'Sullivan, MBBCh, MD, FRCPath – Children's Health Ireland & Trinity College, Dublin, IRELAND ### 1136423###Chair###Consultant/Professor###Children's Health Ireland & Trinity College, Dublin, IRELAND###
Chair: Maureen J. O'Sullivan, MBBCh, MD, FRCPath – Children's Health Ireland & Trinity College, Dublin, IRELAND
### @@@ Cristina R. Antonescu, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 1131959###Moderator###Attending Pathologist###Memorial Sloan Kettering Cancer Center###
Moderator: Cristina R. Antonescu, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Franck Tirode, PhD (he/him/his) – CENTRE LEON BERARD AND CANCER RESEARCH CENTER OF LYON (INSERM U1052-CNRS5286) ### 2101907###Moderator###Team Leader###CENTRE LEON BERARD AND CANCER RESEARCH CENTER OF LYON (INSERM U1052-CNRS5286)###
Moderator: Franck Tirode, PhD (he/him/his) – CENTRE LEON BERARD AND CANCER RESEARCH CENTER OF LYON (INSERM U1052-CNRS5286)
### he/him/his @@@ Emanuela Palmerini, MD, PhD (she/her/hers) – IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy ### 2102499###Moderator###Consultant Medical Oncologist###IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy###
Moderator: Emanuela Palmerini, MD, PhD (she/her/hers) – IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
### she/her/hers
Session 7: Novel Diagnostics and Bioinfomatics
Favorite

Maureen J. O'Sullivan, MBBCh, MD, FRCPath – Children's Health Ireland & Trinity College, Dublin, IRELAND ### 1136423###Chair###Consultant/Professor###Children's Health Ireland & Trinity College, Dublin, IRELAND###
Chair: Maureen J. O'Sullivan, MBBCh, MD, FRCPath – Children's Health Ireland & Trinity College, Dublin, IRELAND
### @@@ Stefan Fröhling, MD (he/him/his) – Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ) ### 1768767###Moderator###Division Head###Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)###
Moderator: Stefan Fröhling, MD (he/him/his) – Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
### he/him/his @@@ Adrienne Margaret Flanagan, MD-PhD (she/her/hers) – University College London, Cancer Institute ### 2101844###Moderator###Academic Head of Research Department of Pathology###University College London, Cancer Institute###
Moderator: Adrienne Margaret Flanagan, MD-PhD (she/her/hers) – University College London, Cancer Institute
### she/her/hers @@@ Adrian Marino-Enriquez, MD, PhD – Brigham and Women's Hospital and Harvard Medical School ### 2102678###Moderator###Molecular Pathologist###Brigham and Women's Hospital and Harvard Medical School###
Moderator: Adrian Marino-Enriquez, MD, PhD – Brigham and Women's Hospital and Harvard Medical School
###
Session 8: Adolescent and Young Adult Sarcomas
Favorite

B Ashleigh Guadagnolo, MD,MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2102052###Chair###Professor###The University of Texas MD Anderson Cancer Center###
Chair: B Ashleigh Guadagnolo, MD,MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Damon Reed, MD – Moffitt Cancer Center ### 2101992###Moderator######Moffitt Cancer Center###
Moderator: Damon Reed, MD – Moffitt Cancer Center
### @@@ Nathalie Gaspar, PhD MD (she/her/hers) – Gustave Roussy cancer campus ### 2102289###Moderator###Dr at Gustave Roussy ###Gustave Roussy cancer campus###
Moderator: Nathalie Gaspar, PhD MD (she/her/hers) – Gustave Roussy cancer campus
### she/her/hers @@@ Scheryll Alken, MB, BCh, BAO (she/her/hers) – Children's Health Ireland/St James's Hospital ### 2128329###Moderator###Medical Oncologist s.i Adolescent & Young Adult Cancer###Children's Health Ireland/St James's Hospital###
Moderator: Scheryll Alken, MB, BCh, BAO (she/her/hers) – Children's Health Ireland/St James's Hospital
### she/her/hers
Session 9: Orthopedic & Reconstructive Surgery
Favorite

Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON ### 2101973###Chair###Surgical Oncologist Clinician-Scientist Associate Professor of Surgery###Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON###
Chair: Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
### she/her/hers @@@ Matthew T. Houdek, MD (he/him/his) – Mayo Clinic ### 2102099###Moderator###Associate Professor Orthopedic Surgery###Mayo Clinic###
Moderator: Matthew T. Houdek, MD (he/him/his) – Mayo Clinic
### he/him/his @@@ Bruno Fuchs, MD PhD – Swiss Sarcoma Network ### 1431415###Moderator###Professor###Swiss Sarcoma Network###
Moderator: Bruno Fuchs, MD PhD – Swiss Sarcoma Network
### @@@ Maria Anna Smolle, PD MD – Department of Orthopaedics and Trauma, Medical University of Graz, Austria ### 1429509###Moderator###Priv.-Doz. DDr.###Department of Orthopaedics and Trauma, Medical University of Graz, Austria###
Moderator: Maria Anna Smolle, PD MD – Department of Orthopaedics and Trauma, Medical University of Graz, Austria
###
SEVERE FEAR OF RECURRENCE OR PROGRESSION, SYMPTOMS OF ANXIETY AND DEPRESSION IN GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS IN THE NETHERLANDS: DATA FROM A CROSS-SECTIONAL MULTICENTER STUDY (Paper 87)
Favorite

Deborah van de Wal, MD – Netherlands Cancer Institute/ Antoni van Leeuwenhoek ### 2102636###Author###PhD candidate###Netherlands Cancer Institute/ Antoni van Leeuwenhoek###
Author: Deborah van de Wal, MD – Netherlands Cancer Institute/ Antoni van Leeuwenhoek
### @@@ Dide den Hollander, MD, PhD (she/her/hers) – Radboud University Medical Center ### 2102643###Co-Author###Resident###Radboud University Medical Center###
Co-Author: Dide den Hollander, MD, PhD (she/her/hers) – Radboud University Medical Center
### she/her/hers @@@ Ingrid M. Desar, MD PhD – Radboud University Medical Center ### 2102210###Co-Author######Radboud University Medical Center###
Co-Author: Ingrid M. Desar, MD PhD – Radboud University Medical Center
### @@@ Hans Gelderblom, MD, PhD (he/him/his) – Leiden University Medical Center ### 2101884###Co-Author###Medical Oncologist###Leiden University Medical Center###
Co-Author: Hans Gelderblom, MD, PhD (he/him/his) – Leiden University Medical Center
### he/him/his @@@ Astrid W. Oosten, MD PhD (she/her/hers) – Erasmus MC Cancer Institute ### 2102209###Co-Author###Medical Oncologist ###Erasmus MC Cancer Institute###
Co-Author: Astrid W. Oosten, MD PhD (she/her/hers) – Erasmus MC Cancer Institute
### she/her/hers @@@ An Reyners, Prof. Dr. – University medical center Groningen ### 2102208###Co-Author###Medical oncologist###University medical center Groningen###
Co-Author: An Reyners, Prof. Dr. – University medical center Groningen
### @@@ Neeltje Steeghs, Dr. – Netherlands Cancer Institute/ Antoni van Leeuwenhoek ### 2102212###Co-Author###Medical Oncologist###Netherlands Cancer Institute/ Antoni van Leeuwenhoek###
Co-Author: Neeltje Steeghs, Dr. – Netherlands Cancer Institute/ Antoni van Leeuwenhoek
### @@@ Winette T. van der Graaf, Prof. Dr. – Netherlands Cancer Institute/ Antoni van Leeuwenhoek ### 2102211###Co-Author###Head of Department of Medical Oncology###Netherlands Cancer Institute/ Antoni van Leeuwenhoek###
Co-Author: Winette T. van der Graaf, Prof. Dr. – Netherlands Cancer Institute/ Antoni van Leeuwenhoek
### @@@ Olga Husson, PhD (she/her/hers) – Netherlands Cancer Institute ### 2102622###Co-Author###Associate Group Leader###Netherlands Cancer Institute###
Co-Author: Olga Husson, PhD (she/her/hers) – Netherlands Cancer Institute
### she/her/hers Paper 87
SIGNIFICANCE OF EARLY LOCAL PROGRESSION IN NEWLY DIAGNOSED HIGH-GRADE OSTEOSARCOMA- A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (Paper 67)
Favorite

Odion Binitie, MD – H. Lee Moffitt Cancer Center ### 2101986###Author###Associate Professor###H. Lee Moffitt Cancer Center###
Author: Odion Binitie, MD – H. Lee Moffitt Cancer Center
### @@@ Mark Krailo, PhD – University of Southern California ### 2101984###Co-Author###Professor###University of Southern California###
Co-Author: Mark Krailo, PhD – University of Southern California
### @@@ Ruxu Han, MS – Children's Oncology Group ### 2102055###Co-Author######Children's Oncology Group###
Co-Author: Ruxu Han, MS – Children's Oncology Group
### @@@ Elyssa Rubin, MD – Children's Hospital of Orange County ### 2102056###Co-Author###PSF Director of Bone and Soft Tissue Tumor Program###Children's Hospital of Orange County###
Co-Author: Elyssa Rubin, MD – Children's Hospital of Orange County
### @@@ Holcombe Grier, MD – Dana Farber Cancer Institute ### 2102057###Co-Author######Dana Farber Cancer Institute###
Co-Author: Holcombe Grier, MD – Dana Farber Cancer Institute
### @@@ Paul Meyers, MD (he/him/his) – Memorial Sloan Kettering Cancer Center ### 2102058###Co-Author###Vice Chair Department of Pediatrics###Memorial Sloan Kettering Cancer Center###
Co-Author: Paul Meyers, MD (he/him/his) – Memorial Sloan Kettering Cancer Center
### he/him/his @@@ Steven G. Dubois, MD, MS – Dana-Farber/Boston Children’s Cancer and Blood Disorders Center ### 2101993###Co-Author###Associate Professor###Dana-Farber/Boston Children’s Cancer and Blood Disorders Center###
Co-Author: Steven G. Dubois, MD, MS – Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
### @@@ Damon Reed, MD – Moffitt Cancer Center ### 2101992###Co-Author######Moffitt Cancer Center###
Co-Author: Damon Reed, MD – Moffitt Cancer Center
### @@@ Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center ### 2101994###Co-Author######Dana-Farber/Boston Children's Cancer and Blood Disorders Center###
Co-Author: Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center
### @@@ Lara Davis, MD (she/her/hers) – OHSU Knight Cancer Institute ### 2102059###Co-Author###Associate Professor###OHSU Knight Cancer Institute###
Co-Author: Lara Davis, MD (she/her/hers) – OHSU Knight Cancer Institute
### she/her/hers Paper 67
SOFT-TISSUE RECONSTRUCTION FOLLOWING TYPE III INTERNAL HEMIPELVECTOMY FOR PELVIC TUMORS: A 20 YEAR SINGLE INSTITUTION STUDY OF SURGICAL AND FUNCTIONAL OUTCOMES (Paper 56)
Favorite

Brooke E. Willborg, MD (she/her/hers) – Mayo Clinic ### 2102093###Author###Resident Physician###Mayo Clinic###
Author: Brooke E. Willborg, MD (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Cristina Salinas, BS – Mayo Clinic ### 2102094###Co-Author###MS4###Mayo Clinic###
Co-Author: Cristina Salinas, BS – Mayo Clinic
### @@@ Matthew Rode, n/a – Mayo Clinic ### 2102095###Co-Author######Mayo Clinic###
Co-Author: Matthew Rode, n/a – Mayo Clinic
### @@@ Barbara Mullen, MD – Mayo Clinic ### 2102097###Co-Author######Mayo Clinic###
Co-Author: Barbara Mullen, MD – Mayo Clinic
### @@@ Samuel Broida, MD – Mayo Clinic ### 2102098###Co-Author###Resident###Mayo Clinic###
Co-Author: Samuel Broida, MD – Mayo Clinic
### @@@ Matthew T. Houdek, MD (he/him/his) – Mayo Clinic ### 2102099###Co-Author###Associate Professor Orthopedic Surgery###Mayo Clinic###
Co-Author: Matthew T. Houdek, MD (he/him/his) – Mayo Clinic
### he/him/his @@@ Steven Moran, MD – Mayo Clinic ### 2102100###Co-Author######Mayo Clinic###
Co-Author: Steven Moran, MD – Mayo Clinic
### Paper 56
SPAGN Mentee Lunch
Favorite
SPAGN Patient Advocacy Reception
Favorite
STRASS2: A RANDOMIZED PHASE III STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH-RISK RETROPERITONEAL SARCOMA (Paper 60)
Favorite

Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute/ Antoni van Leeuwenhoek ### 2101972###Author###Surgical Oncology###Netherlands Cancer Institute/ Antoni van Leeuwenhoek###
Author: Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute/ Antoni van Leeuwenhoek
### @@@ Sandrine Marreaud, MD – European Organisation for Research and Treatment of Cancer ### 2102639###Co-Author######European Organisation for Research and Treatment of Cancer###
Co-Author: Sandrine Marreaud, MD – European Organisation for Research and Treatment of Cancer
### @@@ Saskia Litière, MSc, PhD (she/her/hers) – European Organisation for Research and Treatment of Cancer ### 2102640###Co-Author###Head of Statistics Department###European Organisation for Research and Treatment of Cancer###
Co-Author: Saskia Litière, MSc, PhD (she/her/hers) – European Organisation for Research and Treatment of Cancer
### she/her/hers @@@ Felix B. Oppong, Msc. – European Organization for Research and Treatment of Cancer ### 2102641###Co-Author###Statistician###European Organization for Research and Treatment of Cancer###
Co-Author: Felix B. Oppong, Msc. – European Organization for Research and Treatment of Cancer
### @@@ Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada ### 2101979###Co-Author######Mount Sinai Hospital, Toronto, ON, Canada###
Co-Author: Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada
### @@@ David E Gyorki, MD (he/him/his) – Peter MacCallum Cancer Centre ### 2102421###Co-Author###Surgical Oncologist###Peter MacCallum Cancer Centre###
Co-Author: David E Gyorki, MD (he/him/his) – Peter MacCallum Cancer Centre
### he/him/his @@@ Toshifumi Ozaki, MD – Okayama University Hospital ### 2102642###Co-Author######Okayama University Hospital###
Co-Author: Toshifumi Ozaki, MD – Okayama University Hospital
### @@@ Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School ### 1137185###Co-Author###Surgical Oncologist###Brigham and Women’s Hospital/Harvard Medical School###
Co-Author: Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School
### he/him/his @@@ Kenneth Cardona, MD – Department of Surgery, Winship Cancer Institute, Emory University ### 2102428###Co-Author###Associate Chief Medical Officer, Winship Cancer Institute of Emory###Department of Surgery, Winship Cancer Institute, Emory University###
Co-Author: Kenneth Cardona, MD – Department of Surgery, Winship Cancer Institute, Emory University
### @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2101980###Co-Author###Chief Sarcoma Service and Chair of the Department of Surgery###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### he/him/his Paper 60
STUDY OF THE SPATIAL HETEROGENEITY OF THE OSTEOSARCOMA MICROENVIRONMENT IN THE RESISTANCE TO TREATMENT BY DIGITAL PATHOLOGY : MECANOBIOLOGICAL APPROACHES (Paper 69)
Favorite

Anne Gomez-Mascard, MD, PhD – Institut Universitaire du Cancer de Toulouse ### 2102151###Author###Professor###Institut Universitaire du Cancer de Toulouse###
Author: Anne Gomez-Mascard, MD, PhD – Institut Universitaire du Cancer de Toulouse
### @@@ Pauline Assemat, PhD – Institut Mécanique des fluides IMFT ### 2102152###Co-Author###Researcher###Institut Mécanique des fluides IMFT###
Co-Author: Pauline Assemat, PhD – Institut Mécanique des fluides IMFT
### @@@ Antony Mancini, PhD – Institut mécanique des fluides IMFT ### 2102153###Co-Author######Institut mécanique des fluides IMFT###
Co-Author: Antony Mancini, PhD – Institut mécanique des fluides IMFT
### @@@ Pascal Swider, PhD – Institut Mécanique des fluides IMFT ### 2102154###Co-Author###Professor###Institut Mécanique des fluides IMFT###
Co-Author: Pascal Swider, PhD – Institut Mécanique des fluides IMFT
### Paper 69
SURGERY OR NO_SURGERY: -- A CONUDRUM FOR SARCOMA SPECIALISTS (Video 05)
Favorite

Jiping Wang, MD, PhD (he/him/his) – BWH ### 1430570###Video Presenter###Associate Professor###BWH###
Video Presenter: Jiping Wang, MD, PhD (he/him/his) – BWH
### he/him/his @@@ Lily Saadat, MD – BWH ### 2125305###Co-Author######BWH###
Co-Author: Lily Saadat, MD – BWH
### @@@ Shengnan Wang, MSc – DFCI ### 2125306###Co-Author######DFCI###
Co-Author: Shengnan Wang, MSc – DFCI
### @@@ Jun Xiao, MD – BWH ### 2125307###Co-Author######BWH###
Co-Author: Jun Xiao, MD – BWH
### Video 05